Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

DermaRite Industries, LLC

US Class II Ongoing · initiated 2025-08-27

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2025-08-26

Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.

B BRAUN MEDICAL INC

US Class II Ongoing · initiated 2025-08-26

Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.

AvKARE

US Class II Ongoing · initiated 2025-08-25

Presence of a foreign substance.

AvKARE

US Class II Ongoing · initiated 2025-08-25

Presence of a foreign substance.

Consumer Product Partners, LLC

US Class III Ongoing · initiated 2025-08-25

Cross Contamination with Other Products.

Consumer Product Partners, LLC

US Class III Ongoing · initiated 2025-08-25

Cross Contamination with Other Products.

GRACE & FIRE PTY LTD

US Class II Ongoing · initiated 2025-08-22

Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.

GRACE & FIRE PTY LTD

US Class II Ongoing · initiated 2025-08-22

Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.

DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC

Canada Type III Ongoing · initiated 2025-08-22

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Ultra Albumin Gold

Canada Type III Ongoing · initiated 2025-08-22

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Super Probiotics

Canada Type III Ongoing · initiated 2025-08-22

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Super Germiphene & Oro Clense

Canada Type III Ongoing · initiated 2025-08-21

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

US Class II Ongoing · initiated 2025-08-20

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm